nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Irinotecan—colon cancer	0.276	0.402	CbGbCtD
Gadobenate Dimeglumine—ALB—Fluorouracil—colon cancer	0.265	0.386	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—colon cancer	0.146	0.213	CbGbCtD
Gadobenate Dimeglumine—Pulmonary oedema—Methotrexate—colon cancer	0.000687	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000677	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Capecitabine—colon cancer	0.000673	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Vincristine—colon cancer	0.000672	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Fluorouracil—colon cancer	0.000665	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000663	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Irinotecan—colon cancer	0.000655	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Irinotecan—colon cancer	0.000651	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Capecitabine—colon cancer	0.00065	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Fluorouracil—colon cancer	0.000648	0.00207	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Vincristine—colon cancer	0.000642	0.00205	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Capecitabine—colon cancer	0.000639	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Irinotecan—colon cancer	0.000628	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Irinotecan—colon cancer	0.000626	0.002	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Capecitabine—colon cancer	0.000625	0.002	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Capecitabine—colon cancer	0.000623	0.00199	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Vincristine—colon cancer	0.000622	0.00199	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Irinotecan—colon cancer	0.00061	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Irinotecan—colon cancer	0.000607	0.00194	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Irinotecan—colon cancer	0.000606	0.00194	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Vincristine—colon cancer	0.0006	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Fluorouracil—colon cancer	0.000599	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Irinotecan—colon cancer	0.000595	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Vincristine—colon cancer	0.000592	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Cough—Irinotecan—colon cancer	0.000591	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Capecitabine—colon cancer	0.000586	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Irinotecan—colon cancer	0.000584	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Fluorouracil—colon cancer	0.00058	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Capecitabine—colon cancer	0.00058	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Capecitabine—colon cancer	0.00058	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000579	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Capecitabine—colon cancer	0.00057	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Irinotecan—colon cancer	0.000569	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Vincristine—colon cancer	0.000567	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Infection—Vincristine—colon cancer	0.000563	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Capecitabine—colon cancer	0.000563	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Capecitabine—colon cancer	0.000563	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Irinotecan—colon cancer	0.000557	0.00178	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Vincristine—colon cancer	0.000556	0.00178	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Capecitabine—colon cancer	0.000553	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Irinotecan—colon cancer	0.000552	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Fluorouracil—colon cancer	0.000552	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Fluorouracil—colon cancer	0.000552	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Infection—Irinotecan—colon cancer	0.000549	0.00175	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Vincristine—colon cancer	0.000548	0.00175	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Fluorouracil—colon cancer	0.000545	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Shock—Irinotecan—colon cancer	0.000543	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Irinotecan—colon cancer	0.000542	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Irinotecan—colon cancer	0.000534	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Fluorouracil—colon cancer	0.000533	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Vincristine—colon cancer	0.00053	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Capecitabine—colon cancer	0.00053	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Fluorouracil—colon cancer	0.000529	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Infection—Fluorouracil—colon cancer	0.000526	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Capecitabine—colon cancer	0.000522	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Fluorouracil—colon cancer	0.000519	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Capecitabine—colon cancer	0.000518	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Methotrexate—colon cancer	0.000517	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000517	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Fluorouracil—colon cancer	0.000516	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Irinotecan—colon cancer	0.000516	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Capecitabine—colon cancer	0.000514	0.00164	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Capecitabine—colon cancer	0.000513	0.00164	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Capecitabine—colon cancer	0.000511	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Capecitabine—colon cancer	0.00051	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Vincristine—colon cancer	0.000509	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Capecitabine—colon cancer	0.000501	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Irinotecan—colon cancer	0.000496	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Fluorouracil—colon cancer	0.000494	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Irinotecan—colon cancer	0.000492	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Irinotecan—colon cancer	0.000491	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Vincristine—colon cancer	0.00049	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Vincristine—colon cancer	0.000489	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Capecitabine—colon cancer	0.000486	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Irinotecan—colon cancer	0.000486	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Capecitabine—colon cancer	0.000485	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Vincristine—colon cancer	0.000485	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Pain—Vincristine—colon cancer	0.000485	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Methotrexate—colon cancer	0.000484	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Capecitabine—colon cancer	0.000483	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Capecitabine—colon cancer	0.000483	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000482	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000477	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Irinotecan—colon cancer	0.000476	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Fluorouracil—colon cancer	0.000475	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Pain—Irinotecan—colon cancer	0.000472	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Irinotecan—colon cancer	0.000472	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Capecitabine—colon cancer	0.000472	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Fluorouracil—colon cancer	0.000472	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Fluorouracil—colon cancer	0.00047	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Capecitabine—colon cancer	0.00047	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Capecitabine—colon cancer	0.000469	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Chills—Capecitabine—colon cancer	0.000467	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Fluorouracil—colon cancer	0.000466	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Capecitabine—colon cancer	0.000465	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Methotrexate—colon cancer	0.000464	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vincristine—colon cancer	0.000464	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000457	0.00146	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Capecitabine—colon cancer	0.000456	0.00146	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Irinotecan—colon cancer	0.000455	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Capecitabine—colon cancer	0.000453	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Capecitabine—colon cancer	0.000453	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Pain—Fluorouracil—colon cancer	0.000452	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Irinotecan—colon cancer	0.000452	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Vincristine—colon cancer	0.000448	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vincristine—colon cancer	0.000448	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Capecitabine—colon cancer	0.000444	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Capecitabine—colon cancer	0.000438	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Irinotecan—colon cancer	0.000437	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Irinotecan—colon cancer	0.000437	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Fluorouracil—colon cancer	0.000436	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Capecitabine—colon cancer	0.000436	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—colon cancer	0.000432	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—colon cancer	0.000432	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Capecitabine—colon cancer	0.000424	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—colon cancer	0.000424	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Capecitabine—colon cancer	0.00042	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Fluorouracil—colon cancer	0.00042	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—colon cancer	0.000419	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Capecitabine—colon cancer	0.000419	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Fluorouracil—colon cancer	0.000418	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vincristine—colon cancer	0.000418	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—colon cancer	0.000414	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—colon cancer	0.000411	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Capecitabine—colon cancer	0.000408	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Irinotecan—colon cancer	0.000407	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vincristine—colon cancer	0.000407	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Capecitabine—colon cancer	0.000406	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Capecitabine—colon cancer	0.000405	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Capecitabine—colon cancer	0.0004	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Capecitabine—colon cancer	0.000398	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Irinotecan—colon cancer	0.000396	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Cough—Capecitabine—colon cancer	0.000395	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Capecitabine—colon cancer	0.000391	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Fluorouracil—colon cancer	0.00039	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vincristine—colon cancer	0.000388	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Capecitabine—colon cancer	0.000386	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Capecitabine—colon cancer	0.000386	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Capecitabine—colon cancer	0.000386	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Capecitabine—colon cancer	0.000384	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000383	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—colon cancer	0.000383	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Capecitabine—colon cancer	0.000381	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—colon cancer	0.00038	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Irinotecan—colon cancer	0.000378	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Capecitabine—colon cancer	0.000377	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vincristine—colon cancer	0.000375	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Fluorouracil—colon cancer	0.000374	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—colon cancer	0.000373	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Capecitabine—colon cancer	0.000373	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Infection—Capecitabine—colon cancer	0.000367	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Irinotecan—colon cancer	0.000365	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Shock—Capecitabine—colon cancer	0.000364	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Capecitabine—colon cancer	0.000363	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—colon cancer	0.000362	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Fluorouracil—colon cancer	0.000362	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—colon cancer	0.000361	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Capecitabine—colon cancer	0.000361	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vincristine—colon cancer	0.000361	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—colon cancer	0.00036	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Capecitabine—colon cancer	0.000359	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vincristine—colon cancer	0.000358	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Capecitabine—colon cancer	0.000357	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vincristine—colon cancer	0.000357	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vincristine—colon cancer	0.000355	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—colon cancer	0.000351	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Irinotecan—colon cancer	0.000351	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—colon cancer	0.00035	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—colon cancer	0.00035	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—colon cancer	0.000349	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Rash—Irinotecan—colon cancer	0.000348	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Irinotecan—colon cancer	0.000348	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—colon cancer	0.000348	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Headache—Irinotecan—colon cancer	0.000346	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Capecitabine—colon cancer	0.000345	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—colon cancer	0.000339	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—colon cancer	0.000337	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—colon cancer	0.000337	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vincristine—colon cancer	0.000337	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000337	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—colon cancer	0.000336	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—colon cancer	0.000334	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—colon cancer	0.000333	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Capecitabine—colon cancer	0.000332	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—colon cancer	0.000331	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—colon cancer	0.00033	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Capecitabine—colon cancer	0.00033	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irinotecan—colon cancer	0.000328	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—colon cancer	0.000326	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Capecitabine—colon cancer	0.000325	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000319	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Capecitabine—colon cancer	0.000319	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Pain—Capecitabine—colon cancer	0.000316	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Capecitabine—colon cancer	0.000316	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—colon cancer	0.000314	0.001	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—colon cancer	0.000313	0.000999	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—colon cancer	0.000312	0.000996	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Capecitabine—colon cancer	0.000305	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—colon cancer	0.000304	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Capecitabine—colon cancer	0.000302	0.000966	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—colon cancer	0.000302	0.000964	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—colon cancer	0.000294	0.00094	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Capecitabine—colon cancer	0.000294	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Capecitabine—colon cancer	0.000292	0.000933	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Capecitabine—colon cancer	0.000292	0.000933	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—colon cancer	0.000287	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—colon cancer	0.000287	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—colon cancer	0.000287	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000285	0.000911	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—colon cancer	0.000284	0.000906	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—colon cancer	0.000277	0.000886	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—colon cancer	0.000275	0.000879	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—colon cancer	0.000273	0.000873	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Capecitabine—colon cancer	0.000272	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—colon cancer	0.00027	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—colon cancer	0.000267	0.000854	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—colon cancer	0.000266	0.00085	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Capecitabine—colon cancer	0.000265	0.000847	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Capecitabine—colon cancer	0.000262	0.000835	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—colon cancer	0.000257	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Capecitabine—colon cancer	0.000253	0.000808	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000251	0.000801	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—colon cancer	0.000247	0.000789	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—colon cancer	0.000245	0.000784	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—colon cancer	0.000245	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Capecitabine—colon cancer	0.000244	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—colon cancer	0.000242	0.000774	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000238	0.000759	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—colon cancer	0.000237	0.000758	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—colon cancer	0.000235	0.000752	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Capecitabine—colon cancer	0.000235	0.000751	CcSEcCtD
Gadobenate Dimeglumine—Rash—Capecitabine—colon cancer	0.000233	0.000745	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Capecitabine—colon cancer	0.000233	0.000744	CcSEcCtD
Gadobenate Dimeglumine—Headache—Capecitabine—colon cancer	0.000232	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—colon cancer	0.000227	0.000724	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—colon cancer	0.000225	0.000719	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Capecitabine—colon cancer	0.00022	0.000701	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—colon cancer	0.000219	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—colon cancer	0.000218	0.000695	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—colon cancer	0.000218	0.000695	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—colon cancer	0.000203	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—colon cancer	0.000197	0.000631	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—colon cancer	0.000195	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—colon cancer	0.000188	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—colon cancer	0.000182	0.000581	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—colon cancer	0.000175	0.000559	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—colon cancer	0.000174	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—colon cancer	0.000173	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—colon cancer	0.000172	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—colon cancer	0.000163	0.000522	CcSEcCtD
